Literature DB >> 11108571

Retrovirus-mediated gene transfer of granulocyte colony-stimulating factor receptor (G-CSFR) cDNA into MDS cells and induction of their differentiation by G-CSF.

S Nakamura1, K Ohnishi, H Yoshida, K Shinjo, A Takeshita, K Tohyama, R Ohno, Y Koide.   

Abstract

Myelodysplastic syndromes (MDS) are clonal disorders in which the proper differentiation of hematopoietic stem cells is impaired. There is no effective treatment for this stem cell disorder at present. In an attempt to find a new strategy that promotes the differentiation of MDS blast cells, we tried retroviral transduction of granulocyte colony-stimulating factor receptor (G-CSFR) into an interleukin-3-dependent MDS cell line, MDS-L, since expression of G-CSFR is known to be essential for the differentiation of myeloid progenitor cells and this expression is impaired in most MDS cells. Ectopic expression of human G-CSFR cDNA in MDS-L cells gave rise to granulocytic differentiation by G-CSF stimulation. G-CSF caused the transformants expressing G-CSFR to display a morphological characteristic of mature granulocytes, upregulated CD11b on the cell surface, and improved NBT reduction activity. These results demonstrate that MDS-L cells ecopically expressing G-CSFR are induced to granulocytic differentiation upon exposure to G-CSF, and shed light on the molecular mechanisms of maturation arrest in MDS cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11108571     DOI: 10.1080/13684730050515787

Source DB:  PubMed          Journal:  Cytokines Cell Mol Ther        ISSN: 1368-4736


  10 in total

1.  CD123 CAR T cells for the treatment of myelodysplastic syndrome.

Authors:  Brett M Stevens; Wei Zhang; Daniel A Pollyea; Amanda Winters; Jonathan Gutman; Clayton Smith; Elizabeth Budde; Stephen J Forman; Craig T Jordan; Enkhtsetseg Purev
Journal:  Exp Hematol       Date:  2019-05-25       Impact factor: 3.084

2.  RNAi screening of the kinome with cytarabine in leukemias.

Authors:  Raoul Tibes; James M Bogenberger; Leena Chaudhuri; R Tanner Hagelstrom; Donald Chow; Megan E Buechel; Irma M Gonzales; Tim Demuth; James Slack; Ruben A Mesa; Esteban Braggio; Hongwei H Yin; Shilpi Arora; David O Azorsa
Journal:  Blood       Date:  2012-01-20       Impact factor: 22.113

3.  The helix-loop-helix transcription factor TWIST is dysregulated in myelodysplastic syndromes.

Authors:  Xiang Li; A Mario Marcondes; Theodore A Gooley; H Joachim Deeg
Journal:  Blood       Date:  2010-06-18       Impact factor: 22.113

4.  Cooperation between KDM6B overexpression and TET2 deficiency in the pathogenesis of chronic myelomonocytic leukemia.

Authors:  Yue Wei; Rashmi Kanagal-Shamanna; Hong Zheng; Naran Bao; Pamela Pennington Lockyer; Caleb A Class; Faezeh Darbaniyan; Yue Lu; Kevin Lin; Hui Yang; Guillermo Montalban-Bravo; Irene Ganan-Gomez; Kelly A Soltysiak; Kim-Anh Do; Simona Colla; Guillermo Garcia-Manero
Journal:  Leukemia       Date:  2022-06-14       Impact factor: 12.883

5.  The Coming of Age of Preclinical Models of MDS.

Authors:  Wei Liu; Patric Teodorescu; Stephanie Halene; Gabriel Ghiaur
Journal:  Front Oncol       Date:  2022-03-16       Impact factor: 5.738

6.  A subset of myeloid dendritic cells derived from peripheral blood monocytes represented a predominant subset characterized by their potential tumor-inhibiting activity.

Authors:  Min Wang; Jun Shi; Yun Wan; Jing Li; Yinghua Yuan
Journal:  In Vitro Cell Dev Biol Anim       Date:  2009-03-14       Impact factor: 2.416

7.  The Hedgehog pathway as targetable vulnerability with 5-azacytidine in myelodysplastic syndrome and acute myeloid leukemia.

Authors:  Raoul Tibes; Aref Al-Kali; Gavin R Oliver; Devora H Delman; Nanna Hansen; Keerthi Bhagavatula; Jayaram Mohan; Fariborz Rakhshan; Thomas Wood; James M Foran; Ruben A Mesa; James M Bogenberger
Journal:  J Hematol Oncol       Date:  2015-10-20       Impact factor: 17.388

8.  Functional expression of Tim-3 on blasts and clinical impact of its ligand galectin-9 in myelodysplastic syndromes.

Authors:  Toshio Asayama; Hideto Tamura; Mariko Ishibashi; Yasuko Kuribayashi-Hamada; Asaka Onodera-Kondo; Namiko Okuyama; Akiko Yamada; Masumi Shimizu; Keiichi Moriya; Hidemi Takahashi; Koiti Inokuchi
Journal:  Oncotarget       Date:  2017-10-04

9.  Characterization of clinical grade CD19 chimeric antigen receptor T cells produced using automated CliniMACS Prodigy system.

Authors:  Wei Zhang; Kimberly R Jordan; Brian Schulte; Enkhtsetseg Purev
Journal:  Drug Des Devel Ther       Date:  2018-10-05       Impact factor: 4.162

10.  Overexpression of miR-125a in myelodysplastic syndrome CD34+ cells modulates NF-κB activation and enhances erythroid differentiation arrest.

Authors:  Irene Gañán-Gómez; Yue Wei; Hui Yang; Sherry Pierce; Carlos Bueso-Ramos; George Calin; María Del Carmen Boyano-Adánez; Guillermo García-Manero
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.